To study the impact of CD44+ tumors on tumor angiogenesis, Nils Ludwig et al.’s research used tissue microarray technology combined with immunohistochemical methods to analyze the correlation between CD44 expression and microvessel density in HNSCC samples. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.